• Search
  • Helpdesk
  • Sales contact

BYOD: When, why and how?

29 July 2021

What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to be considered when developing a successful BYOD strategy?

COVID-19 acted as a catalyst to clinical trials digitalization. The Bring Your Own Device (BYOD) approach has emerged amongst many alternative ways to collect patients’ data electronically during clinical trials. 

This white paper gathers substantial information on BYOD, describing the several technical options and showing the numerous advantages of such approach for both patients and clinical trials sponsors. Despite the benefits of BYOD techniques, few clinical studies seem to have adopted it, testifying of the current complexity that BYOD implementation encompasses. Technical limits, lack of clear regulatory statements towards acceptance of BYOD data and data privacy risks are examples of the numerous factors at the root of BYOD complexity that this article also proposes to review. It is by increasing their knowledge of both the value and the limits of BYOD that clinical trials’ stakeholders will develop successful BYOD strategies that contribute to clinical trials digitalization.

Download the white paper 👇

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA


13-16 OCT 2024 • Cologne, Germany


10-13 NOV 2024 • Cologne, Germany

DMB 2024

13 NOV 2024 • Paris, France

SCOPE 2025

FEB 3-6 2025 • Orlando, USA
Booth #931 https://www.scopesummit.com/